High expression of HMGCR and DHCR7 correlates with worse overall survival, and single-cell RNA-seq analyses demonstrate broad expression of genes of this pathway across RMS subtypes, irrespective of tumor origin. This evidence concerns the gene HMGCR and neoplasm.